5Watanabe K, Sekiya M, Tsuruoka T, et al. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension[J]. J Hypertens, 1999, 17: 1153-1160.
6Paternostro G, Pagano D, Gnecchi-Ruscone T, et al. Insulin resistance in patients with cardiac hypertrophy[J]. Cardiovasc Res, 1999, 42: 246-253.
7Levy D, Garrison R J, Savage D D, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study[J]. N Engl J Med, 1990, 322: 1561-1566.
8Jiang C, Ting A T, Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines[J]. Nature, 1998, 391(6662): 82-86.
9Delerive P, Martin-Nizard F, Chinetti G, et al. Pero-xisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling patheway[J]. Circ Res, 1999, 85: 394-402.
10Mehrabi M R, Thalhammer T, Haslmayer P,et al. The peroxisome proliferator-activated receptor gamma (PPARγ) is highly expressed in human heart ventricles[J]. Biomed Pharmacother, 2002, 56: 407-410.
